COMPASS Pathways plc (CMPS) Reports Q3 2022 Financial Results
COMPASS Pathways plc (CMPS) announced its financial results for the period ending Q3 2022.
Key Financial Highlights:
Revenue: Not disclosed
Net Income: Not disclosed
EPS: Not disclosed
Cash and equivalents: 207177
Kabir Nath appointed as Chief Executive Officer
Phase III program submitted to FDA and under review
COMP360 phase II study in anorexia nervosa launched
planned for on 12 October◦Event will also cover commercial strategy, digital tools, and pipeline including KOL perspectives•Phase III TRD program expected to commence in fourth quarter 2022
📋 COMPASS PATHWAYS PLC (CMPS) - Financial Results
Filing Date: 2022-08-04
Accepted: 2022-08-04 07:02:49
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: